These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 20846302

  • 1. Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients.
    D'Arena G, Capalbo S, Laurenti L, Del Poeta G, Nunziata G, Deaglio S, Spinosa G, Tarnani M, De Padua L, Califano C, Ferrara F, Cascavilla N.
    Eur J Haematol; 2010 Dec; 85(6):502-7. PubMed ID: 20846302
    [Abstract] [Full Text] [Related]

  • 2. Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia.
    Oo TH.
    South Med J; 2005 Dec; 98(12):1227-8. PubMed ID: 16440930
    [No Abstract] [Full Text] [Related]

  • 3. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
    Zaja F, Volpetti S, Chiozzotto M, Puglisi S, Isola M, Buttignol S, Fanin R.
    Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
    [Abstract] [Full Text] [Related]

  • 4. Single-agent rituximab in treatment-refractory or poor prognosis patients with chronic lymphocytic leukemia.
    Wiernik PH, Adiga GU.
    Curr Med Res Opin; 2011 Oct; 27(10):1987-93. PubMed ID: 21905969
    [Abstract] [Full Text] [Related]

  • 5. Successful treatment of steroid resistant autoimmune thrombocytopenia associated with chronic lymphocytic leukemia with alemtuzumab.
    Ammatuna E, Marino C, Mitra ME, Calvaruso G, Iannitto E.
    Eur J Haematol; 2004 Sep; 73(3):225-6. PubMed ID: 15287923
    [No Abstract] [Full Text] [Related]

  • 6. Rituximab for the treatment of autoimmune cytopenias.
    Berentsen S.
    Haematologica; 2007 Dec; 92(12):1589-96. PubMed ID: 18055980
    [No Abstract] [Full Text] [Related]

  • 7. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 8. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
    Aleem A.
    Ann Saudi Med; 2008 Oct; 28(5):382-5. PubMed ID: 18779631
    [No Abstract] [Full Text] [Related]

  • 9. Agranulocytosis occurring in a patient with chronic lymphocytic leukemia in complete remission; treatment by rituximab and cyclosporin.
    Costello RT, Sébahoun G.
    Leuk Res; 2010 Dec; 34(12):e329-30. PubMed ID: 20723978
    [No Abstract] [Full Text] [Related]

  • 10. Rituximab therapy for childhood Evans syndrome.
    Bader-Meunier B, Aladjidi N, Bellmann F, Monpoux F, Nelken B, Robert A, Armari-Alla C, Picard C, Ledeist F, Munzer M, Yacouben K, Bertrand Y, Pariente A, Chaussé A, Perel Y, Leverger G.
    Haematologica; 2007 Dec; 92(12):1691-4. PubMed ID: 18055994
    [Abstract] [Full Text] [Related]

  • 11. Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia.
    Arnold DM, Crowther MA, Meyer RM, Carruthers J, Ditomasso J, Heddle NM, McLeod A, Kelton JG.
    Transfusion; 2010 Dec; 50(12):2577-81. PubMed ID: 20576011
    [Abstract] [Full Text] [Related]

  • 12. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
    Zaja F, Battista ML, Pirrotta MT, Palmieri S, Montagna M, Vianelli N, Marin L, Cavallin M, Bocchia M, Defina M, Ippoliti M, Ferrara F, Patriarca F, Avanzini MA, Regazzi M, Baccarani M, Isola M, Soldano F, Fanin R.
    Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395
    [Abstract] [Full Text] [Related]

  • 13. Rituximab-induced toxicity.
    Mumoli N, Cei M.
    QJM; 2011 Mar; 104(3):265. PubMed ID: 20228132
    [No Abstract] [Full Text] [Related]

  • 14. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Rossignol J, Michallet AS, Oberic L, Picard M, Garon A, Willekens C, Dulery R, Leleu X, Cazin B, Ysebaert L.
    Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
    [Abstract] [Full Text] [Related]

  • 15. High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.
    Gómez-Almaguer D, Tarín-Arzaga L, Moreno-Jaime B, Jaime-Pérez JC, Ceballos-López AA, Ruiz-Argüelles GJ, Ruiz-Delgado GJ, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Sánchez-Cárdenas M.
    Eur J Haematol; 2013 Jun; 90(6):494-500. PubMed ID: 23470153
    [Abstract] [Full Text] [Related]

  • 16. Modulation of CD20 antigen expression after rituximab treatment: a retrospective study in patients with chronic lymphocytic leukemia.
    D'Auria F, Guariglia R, Villani O, Mansueto G, Grieco V, Zonno A, Bianchino G, Di Giovannantonio L, Vita G, Musto P.
    Clin Ther; 2010 Oct; 32(11):1911-6. PubMed ID: 21095486
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ding W, Zent CS.
    Clin Adv Hematol Oncol; 2007 Apr; 5(4):257-61. PubMed ID: 17607284
    [Abstract] [Full Text] [Related]

  • 18. Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia.
    Jolliffe E, Romeril K.
    Intern Med J; 2014 Jul; 44(7):697-9. PubMed ID: 25041772
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.
    Mahévas M, Ebbo M, Audia S, Bonnotte B, Schleinitz N, Durand JM, Chiche L, Khellaf M, Bierling P, Roudot-Thoraval F, Godeau B, Michel M.
    Am J Hematol; 2013 Oct; 88(10):858-61. PubMed ID: 23798363
    [Abstract] [Full Text] [Related]

  • 20. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up.
    Routy B, Boulassel MR, Spurll GM, Warner MN, Routy JP.
    Am J Ther; 2013 Oct; 20(2):219-22. PubMed ID: 23466621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.